Trial intelligence / Profile preview

Zihua Wenfei Granule for post-cold cough

ChiCTR-IPR-15007286Phase 3Recruiting

Sponsor
Guangdong Provincial Hospital of Traditional Chinese Medicine
Start
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of Zihua Wenfei granule in postinfectious cough (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoints: Cough severity score, Improvement of pharyngeal itching and 2 more. Started Dec 2014; status: recruiting.

02

Drugs

Zihua Wenfei granule
03

Conditions

postinfectious cough

Beyond the preview

Go deeper on ChiCTR-IPR-15007286.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-15007286.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call